| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Rivastigmine tartrate | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing ambenonium (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing edrophonium (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing pyridostigmine (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing neostigmine (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing physostigmine (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Poisoning by reversible anticholinesterase | Causative agent | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing tacrine (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing rivastigmine (medicinal product) | Is a | True | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing precisely rivastigmine (as rivastigmine tartrate) 1.5 milligram/1 each conventional release oral capsule (clinical drug) | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing precisely rivastigmine (as rivastigmine tartrate) 4.5 milligram/1 each conventional release oral capsule (clinical drug) | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Rivastigmine (as rivastigmine tartrate) 6 mg oral capsule | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Neostigmine bromide 15 mg oral tablet | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing precisely pyridostigmine bromide 60 milligram/1 each conventional release oral tablet (clinical drug) | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Ambenonium chloride 10 mg oral tablet | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| atropinsulfat + edrofoniumklorid | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Rivastigmine (as rivastigmine tartrate) 2 mg/mL oral solution | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| glykopyrronbromid och neostigminbromid | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| Product containing precisely pyridostigmine bromide 180 milligram/1 each prolonged-release oral tablet (clinical drug) | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| edrofoniumklorid 150 mg/15 ml, injektionsvätska, lösning, flaska | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| glykopyrrolat 500 mikrogram/ml + neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| edrofoniumklorid 10 mg/ml, injektionsvätska, lösning, ampull | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  | 
| neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull | Is a | False | Product containing reversible anticholinesterase (product) | Inferred relationship | Some |  |